West Pharmaceutical Services Inc (WST)

Currency in USD
239.26
0.00(0.00%)
Closed·
After Hours
239.260.00(0.00%)
·

WST Earnings

Latest Release
Jul 24, 2025
EPS / Forecast
1.84 / 1.51
Revenue / Forecast
766.50M / 725.26M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025--/1.68--/785.94M----Free Sign Up
06/20251.84/1.51766.5M/725.26M+21.85%+5.69%Free Sign Up
03/20251.23/1.23698M/684.94M0%+1.91%Free Sign Up
12/20241.82/1.72748.8M/740.75M+5.81%+1.09%Free Sign Up
09/20241.85/1.5746.9M/709.3M+23.33%+5.3%Free Sign Up
06/20241.52/1.74702.1M/729.36M-12.64%-3.74%Free Sign Up
03/20241.56/1.3695.4M/670.31M+20%+3.74%Free Sign Up
12/20231.83/1.78732M/739.46M+2.81%-1.01%Free Sign Up
09/20232.16/1.86747.4M/749.89M+16.13%-0.33%Free Sign Up
06/20232.11/1.94753.8M/757.43M+8.76%-0.48%Free Sign Up

All numbers in USD

West Pharmaceutical Services Inc Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of $1.84 and revenue of $766.5M beat estimates; stock surged 22.74% in premarket trading
  • Organic sales grew 6.8%; full-year 2025 sales guidance raised to $3.040-$3.060B with 3-3.75% organic growth expected
  • Gross profit up 19.1% YoY to $273.9M; gross margin improved 290 bps to 35.7%; adjusted operating profit margin up 230 bps to 20.3%
  • Strong demand for HVP components and biologics market solutions driving growth; company expanding manufacturing capacity
  • Management anticipates stronger H2 2025 performance, driven by biologics and diabetes markets; adjusted EPS guidance at $6.65-$6.85
Last Updated: 24/07/2025, 14:30
Read Full Transcript

FAQ

What Is West Pharmaceutical Services's Earnings Per Share (TTM)?

The West Pharmaceutical Services EPS (TTM) is 6.73.

When Is The Next West Pharmaceutical Services Earnings Date?

West Pharmaceutical Services will release its next earnings report on 22 Oct 2025.

What Is West Pharmaceutical Services’s Revenue Forecasts For Upcoming Quarters?

West Pharmaceutical Services’s revenue forecast is 785.94M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.